Recent developments in the biology and therapy of T-cell and natural killer-cell lymphomas
Calcium Channel Blockers
Lupus Erythematosus, Cutaneous
Much remains to be learned in the pathogenesis, clinical spectrum, and optimal therapy of T/NK-cell lymphomas. The availability of animal models of disease, new diagnostic tools, and targeted drugs with novel mechanisms of action should lead to rapid progress in this group of malignancies in the near future.